Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06798584 · ClinicalTrials.gov registry record · NA
How Does Perimenopausal Menorrhagia Affect Women's Quality of Life and Cognitive Function?
A NA study, sponsored by Purdue University.
- Not yet
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT06798584: Clinical Trial NA study, sponsored by Purdue University.
NCT06798584 is a NA study that has not yet begun recruiting, run by Purdue University. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06798584, a NA study, has not yet begun recruiting, sponsored by Purdue University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to investigate how iron status and heavy bleeding during the menopausal transition affect women's cognitive function and quality of life. The main questions it aims to answer are: * What is the association between iron status, cognitive function, mood, quality of family relationships, and quality of life in perimenopausal women? * How does iron repletion, via supplementation, affect cognitive function, mood, quality of family relationships, and quality of life in perimenopausal women? The investigators will compare the effect of iron supplements to a placebo (gelatin capsule) to see if iron supplements could improve iron status, cognitive function, mood, quality of family relationships, and quality of life of iron-deficient and/or anemic women undergoing the menopausal transition. Each participant will: * Make 2 visits (about 2 hours each - baseline and endline) to the Clinical Research Center at Purdue * Make a very brief visit at midpoint (about 10 minutes) for a checkup * Take a daily study supplement or placebo for 4 months
Primary Outcome
The investigators will measure plasma iron (mcg/dL).
Interventions
- DIETARY_SUPPLEMENT FeoSol Original Iron Supplement Tablets
- DIETARY_SUPPLEMENT 21st Century Gelatin Capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2025-12 |
| Phase | NA |
What is known before NCT06798584 opens enrollment
NCT06798584 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which FeoSol Original Iron Supplement Tablets is the first listed.
NCT06798584 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06798584 about?
NCT06798584 is a clinical study titled "How Does Perimenopausal Menorrhagia Affect Women's Quality of Life and Cognitive Function?". The goal of this clinical trial is to investigate how iron status and heavy bleeding during the menopausal transition affect women's cognitive function and quality of life. The main questions it aims to answer are: * What is the association between iron status, cognitive function, mood, quality of ...
What is the current status of trial NCT06798584?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2025-03-01. Estimated completion is 2025-12.
What interventions are being tested in trial NCT06798584?
The interventions under investigation include: FeoSol Original Iron Supplement Tablets (DIETARY_SUPPLEMENT), 21st Century Gelatin Capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06798584?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06798584's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI